Company intelligence / Profile preview

BioLab Holdings

Memphis, Tennessee, USA

Ownership: Private
Employees: ~25
Development stage: Other

Overview

BioLab Holdings is a regenerative medicine company specializing in the development and manufacturing of advanced wound care products derived from human birth tissues. Based in Memphis, Tennessee, the company focuses on providing high-quality amniotic and placental allografts to support the healing of chronic and surgical wounds. Their product line includes multi-layered membranes and fluid-based biologics designed to serve as natural scaffolds for tissue repair. BioLab Holdings emphasizes rigorous safety standards and clinical efficacy in its mission to improve patient outcomes in dermatology and surgery.

Therapeutic areas: OtherEndocrinologyDermatologyCardiovascular
Modalities: BiologicHuman Tissue Allograft
Industry: Biotech

Beyond the preview

Go deeper on BioLab Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLab Holdings.

Explore the full profile